Literature DB >> 2496449

Pneumonia caused by Mycoplasma pneumoniae and the TWAR agent.

R L Atmar1, S B Greenberg.   

Abstract

Mycoplasma pneumoniae and the TWAR agent account for a good proportion of pneumonias acquired in the community among older children and young adults. Recovery from these infections is common, although serious complications may occur. Each is associated with fever, nonproductive cough, and headache. The full clinical manifestations of TWAR agent infection are only now beginning to be defined. Diagnosis of M pneumoniae can be by serology and/or culture capabilities. The TWAR agent cannot be routinely isolated and serologic tests are available only in research laboratories. Response to tetracycline antibiotics has been established for each agent and hospitalization is rarely needed. Erythromycin and other macrolide antibiotics have good activity against M pneumoniae and can be employed as an alternative to tetracycline antibiotics for this pathogen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496449

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  8 in total

Review 1.  Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections.

Authors:  K Loens; D Ursi; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 2.  Formulary management of macrolide antibiotics.

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

3.  Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR.

Authors:  Karolina Gullsby; Martin Storm; Kåre Bondeson
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

4.  Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhône-Alpes, France, during five successive winter periods.

Authors:  M P Layani-Milon; I Gras; M Valette; J Luciani; J Stagnara; M Aymard; B Lina
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 5.  Macrolide antibiotics in paediatric infectious diseases.

Authors:  D R Guay
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 6.  Is asthma an infectious disease? New evidence.

Authors:  T Prescott Atkinson
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

7.  Elevation of endothelin biosynthesis in human endothelial cells with mycoplasma infection.

Authors:  M Matsui; M Kobayashi; Y Mitsup
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-12       Impact factor: 2.416

8.  Distributions of antibody titers to Mycoplasma pneumoniae in Korean children in 2000-2003.

Authors:  Jinho Yu; Young Yoo; Do Kyun Kim; Hee Kang; Young Yull Koh
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.